Cargando…
Mortality after transcatheter aortic valve replacement for aortic stenosis among patients with malignancy: a systematic review and meta-analysis
BACKGROUND: With advancements in cancer treatment, the life expectancy of oncology patients has improved. Thus, transcatheter aortic valve replacement (TAVR) may be considered as a feasible option for oncology patients with severe symptomatic aortic stenosis (AS). We aim to evaluate the difference i...
Autores principales: | Siddiqui, Muhammad Umer, Yacob, Omar, Junarta, Joey, Pasha, Ahmed K., Mookadam, Farouk, Mamas, Mamas A., Fischman, David L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088110/ https://www.ncbi.nlm.nih.gov/pubmed/35538411 http://dx.doi.org/10.1186/s12872-022-02651-4 |
Ejemplares similares
-
Prognostic role of CA‐125 in patients undergoing transcatheter aortic valve replacement: A systematic review and meta‐analysis
por: Diaz‐Arocutipa, Carlos, et al.
Publicado: (2023) -
Unequal quadricuspid aortic valve stenosis treated with transcatheter aortic valve replacement
por: Fukui, Tomoki, et al.
Publicado: (2020) -
Transcatheter Aortic Valve Replacement versus Surgical Aortic Valve Replacement: A Review of Aortic Stenosis Management
por: Sattar, Yasar, et al.
Publicado: (2019) -
Transcatheter aortic valve replacement in patients with aortic stenosis and cardiac amyloidosis
por: Khawaja, Tasveer, et al.
Publicado: (2022) -
Multidisciplinary transcatheter aortic valve replacement heart team programme improves mortality in aortic stenosis
por: Jones, Dylan R, et al.
Publicado: (2019)